View in EDS HTML Full Text PDF Full Text

The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.

Saved in:
Bibliographic Details
Title: The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.
Authors: de la Fuente MI; Department of Neurology, University of Miami, Miami, Florida, USA.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Touat M; Service de Neuro-oncologie, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France.; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van den Bent MJ; Service de Neuro-oncologie, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France.; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Peters KB; Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Young RJ; Service Neuroradiology, Department of Radiology, Memorial Sloan Kettering Cancer, New York, New York, USA., Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Capper D; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Berlin, Heidelberg, Germany.; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Phillips JJ; Department of Pathology, University of California San Francisco, San Francisco, California, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Halasz LM; Department of Radiation Oncology, University of Washington/Fred Hutchinson Cancer Center, Seattle, Washington, USA., Shih HA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Rudà R; Division of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy., Lim-Fat MJ; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Blumenthal DT; Neuro-Oncology, Tel Aviv Medical Center, Tel-Aviv University, Tel-Aviv, Israel., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Arakawa Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Whittle JR; Department of Medical Biology, University of Melbourne, Parkville, Australia.; Personalised Oncology Division, WEHI, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Ducray F; Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard, Lyon, France., Reardon DA; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Minniti G; IRCCS Neuromed, Pozzilli, Isernia, Italy.; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy., Rahman R; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hervey-Jumper S; Department of Neurological Surgery, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.; Department of Pathology, University of California San Francisco, San Francisco, California, USA., Chang SM; Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco, California, USA., Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Source: Neuro-oncology [Neuro Oncol] 2025 Jun 21; Vol. 27 (5), pp. 1135-1148.
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39723472
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+la+Fuente+MI%22">de la Fuente MI</searchLink>; Department of Neurology, University of Miami, Miami, Florida, USA.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Touat+M%22">Touat M</searchLink>; Service de Neuro-oncologie, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France.; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Bent+MJ%22">van den Bent MJ</searchLink>; Service de Neuro-oncologie, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France.; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Preusser+M%22">Preusser M</searchLink>; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Peters+KB%22">Peters KB</searchLink>; Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Young+RJ%22">Young RJ</searchLink>; Service Neuroradiology, Department of Radiology, Memorial Sloan Kettering Cancer, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Huang+RY%22">Huang RY</searchLink>; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ellingson+BM%22">Ellingson BM</searchLink>; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Capper+D%22">Capper D</searchLink>; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Berlin, Heidelberg, Germany.; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Phillips+JJ%22">Phillips JJ</searchLink>; Department of Pathology, University of California San Francisco, San Francisco, California, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Halasz+LM%22">Halasz LM</searchLink>; Department of Radiation Oncology, University of Washington/Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Shih+HA%22">Shih HA</searchLink>; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rudà+R%22">Rudà R</searchLink>; Division of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Lim-Fat+MJ%22">Lim-Fat MJ</searchLink>; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Blumenthal+DT%22">Blumenthal DT</searchLink>; Neuro-Oncology, Tel Aviv Medical Center, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Weller+M%22">Weller M</searchLink>; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Arakawa+Y%22">Arakawa Y</searchLink>; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Whittle+JR%22">Whittle JR</searchLink>; Department of Medical Biology, University of Melbourne, Parkville, Australia.; Personalised Oncology Division, WEHI, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Ducray+F%22">Ducray F</searchLink>; Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Reardon+DA%22">Reardon DA</searchLink>; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bi+WL%22">Bi WL</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Minniti+G%22">Minniti G</searchLink>; IRCCS Neuromed, Pozzilli, Isernia, Italy.; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Rahman+R%22">Rahman R</searchLink>; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hervey-Jumper+S%22">Hervey-Jumper S</searchLink>; Department of Neurological Surgery, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.; Department of Pathology, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Chang+SM%22">Chang SM</searchLink>; Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wen+PY%22">Wen PY</searchLink>; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2025 Jun 21; Vol. 27 (5), pp. 1135-1148.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39723472
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/noae259
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1135
    Titles:
      – TitleFull: The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de la Fuente MI
      – PersonEntity:
          Name:
            NameFull: Touat M
      – PersonEntity:
          Name:
            NameFull: van den Bent MJ
      – PersonEntity:
          Name:
            NameFull: Preusser M
      – PersonEntity:
          Name:
            NameFull: Peters KB
      – PersonEntity:
          Name:
            NameFull: Young RJ
      – PersonEntity:
          Name:
            NameFull: Huang RY
      – PersonEntity:
          Name:
            NameFull: Ellingson BM
      – PersonEntity:
          Name:
            NameFull: Capper D
      – PersonEntity:
          Name:
            NameFull: Phillips JJ
      – PersonEntity:
          Name:
            NameFull: Halasz LM
      – PersonEntity:
          Name:
            NameFull: Shih HA
      – PersonEntity:
          Name:
            NameFull: Rudà R
      – PersonEntity:
          Name:
            NameFull: Lim-Fat MJ
      – PersonEntity:
          Name:
            NameFull: Blumenthal DT
      – PersonEntity:
          Name:
            NameFull: Weller M
      – PersonEntity:
          Name:
            NameFull: Arakawa Y
      – PersonEntity:
          Name:
            NameFull: Whittle JR
      – PersonEntity:
          Name:
            NameFull: Ducray F
      – PersonEntity:
          Name:
            NameFull: Reardon DA
      – PersonEntity:
          Name:
            NameFull: Bi WL
      – PersonEntity:
          Name:
            NameFull: Minniti G
      – PersonEntity:
          Name:
            NameFull: Rahman R
      – PersonEntity:
          Name:
            NameFull: Hervey-Jumper S
      – PersonEntity:
          Name:
            NameFull: Chang SM
      – PersonEntity:
          Name:
            NameFull: Wen PY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 06
              Text: 2025 Jun 21
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1